Search

Sartorius Stedim Biotech.

Closed

SectorFinance

179 -1.16

Overview

Share price change

24h

Current

Min

177.5

Max

182.4

Key metrics

By Trading Economics

Income

4.9M

93M

Sales

4.2M

766M

P/E

Sector Avg

56.921

19.1

EPS

1.25

Dividend yield

0.41

Profit margin

12.146

Employees

10,477

EBITDA

9.2M

240M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+26.79% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.41%

4.56%

Next Earnings

22 Oct 2026

Market Stats

By TradingEconomics

Market Cap

-808M

17B

Previous open

180.16

Previous close

179

News Sentiment

By Acuity

13%

87%

12 / 438 Finance

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

10 Aug 2026, 23:56 UTC

News

Iovance Biotherapeutics reported second-quarter revenue of $99.3 million, a 66% increase, contributing to a rise in shares during after-market hours.

10 Aug 2026, 23:52 UTC

Event
News
Social Media

Plug Power shares are higher in after-market trading following strong second-quarter results that exceeded analyst expectations and an improved revenue growth outlook.

10 Aug 2026, 23:51 UTC

News

First Horizon Corp shares rise in after-market hours following James Petrillo's appointment as Vice President, De Novo New Build Leader to enhance banking centers.

10 Aug 2026, 23:51 UTC

News
Social Media

Riot Platforms reported Q2 revenue of $174.2 million, exceeding expectations. Shares rose sharply in after-hours trading following a major data center lease announcement.

10 Aug 2026, 23:51 UTC

News
Social Media

FutureFuel Corp reported second-quarter revenues of $78.7 million, a 120.6% increase year-over-year. Shares are trading higher in after-market hours following the results.

10 Aug 2026, 23:51 UTC

Event
News
Social Media

Upwork Inc. shares fell sharply in after-market hours following disappointing second-quarter results and lowered full-year revenue guidance of $730 million to $750 million.

10 Aug 2026, 23:46 UTC

News

Fortuna Silver Mines acquires the Bambadji Project for $200 million, boosting growth potential in West Africa. Shares are higher in after-market trading.

10 Aug 2026, 23:42 UTC

News

AT&T Inc. filed a $1.1 billion term sheet for floating rate notes due in 2028, contributing to lower shares in after-market trading.

10 Aug 2026, 23:41 UTC

News

Kyndryl Holdings plans to acquire Healthcare IT Leaders to enhance its healthcare capabilities. Shares are trading higher in after-market hours following the announcement.

10 Aug 2026, 23:41 UTC

News

Analysts adjusted price targets for Insmed Inc. after recent evaluations. Shares are higher in after-market trading, reflecting positive sentiment amid these actions.

10 Aug 2026, 23:41 UTC

News

Enphase Energy shares are lower in after-market trading following governance enhancements announced by the board after its 2026 Annual Meeting vote.

10 Aug 2026, 23:41 UTC

News

Toast Inc. shares are trading lower in after-market hours following Elena Gomez's sale of 17,076 shares, reducing her ownership by 9%.

10 Aug 2026, 23:41 UTC

News

Harrow Inc shares declined in after-market hours following a second-quarter EPS miss of -$0.46, despite revenue of $70.66 million exceeding expectations.

10 Aug 2026, 23:41 UTC

News

Hf Foods Group Inc reported strong Q2 results, with revenue of $323.8 million and GAAP net income of $2.6 million, driving shares higher in after-market hours.

10 Aug 2026, 23:41 UTC

News

Curtiss-Wright Corp raised its share repurchase program to $160 million, boosting investor sentiment as shares gained during after-market hours.

10 Aug 2026, 23:41 UTC

News
Social Media

Hims & Hers Health reported a net loss of $86.3 million in Q2, contributing to a decline in share price during after-market trading.

10 Aug 2026, 23:41 UTC

News

Rapid7 shares rise in after-hours trading following second-quarter results that exceeded expectations and positive third-quarter guidance.

10 Aug 2026, 23:41 UTC

Event
News

Alcon AG reported second-quarter adjusted EPS of $0.84, surpassing estimates. The company raised its fiscal 2026 EPS guidance, boosting shares in after-market hours.

10 Aug 2026, 23:41 UTC

News
Social Media

Entravision Communications shares fell sharply after reporting mixed Q2 results, with earnings of $0.19 and revenues of $227.9 million amid declining broadcast advertising revenue.

10 Aug 2026, 23:41 UTC

News

Celsius Holdings Inc. shares are lower in after-market trading following significant leadership changes, including the departure of President Eric Hanson.

10 Aug 2026, 23:36 UTC

News

Purple Innovation shares fell after the company reported Q2 2026 earnings of -$0.74, missing estimates, and reduced full-year revenue guidance to $420 million to $440 million.

10 Aug 2026, 23:36 UTC

Correlated Moves
News

Pomerantz LLP has filed a class action lawsuit against Zillow Group Inc, contributing to a decline in shares during after-market trading.

10 Aug 2026, 23:36 UTC

News

Valero Energy shares are higher in after-market trading, reflecting a five-year average annual return of 36.59%, turning a $100 investment into $468.33.

10 Aug 2026, 23:36 UTC

News

Phillips Edison & Co Inc shares are lower in after-market hours following a $400 million stock sale announcement, raising concerns over potential dilution.

10 Aug 2026, 23:31 UTC

News

Tactile Systems Technology shares fell in after-market hours following a revenue guidance cut, despite a rise in net income and adjusted EBITDA surpassing expectations.

10 Aug 2026, 23:31 UTC

News

L3Harris Technologies completed a successful hot-fire test for the Next Generation Interceptor program, boosting shares in after-market trading.

10 Aug 2026, 23:31 UTC

News

Definitive Healthcare reported Q2 adjusted EPS of $0.05, exceeding estimates. The stock rose sharply during after-market hours amid positive guidance and CEO comments.

10 Aug 2026, 23:26 UTC

News

Rocket Pharmaceuticals reported Q2 net income of $123.2 million, with EPS of $1.08, significantly exceeding estimates. Shares traded higher in after-market hours.

10 Aug 2026, 23:26 UTC

News

RadNet Inc reported record Q2 revenue and adjusted EBITDA. Shares are trading higher in after-market hours, reflecting positive investor sentiment following the earnings report.

10 Aug 2026, 23:21 UTC

News
Social Media

BridgeBio Pharma Inc. reported second-quarter revenues of $243.7 million, exceeding expectations. Shares are higher in after-market trading amid positive reception for Attruby.

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

26.79% upside

12 Months Forecast

Average 230 EUR  26.79%

High 260 EUR

Low 210 EUR

Based on 5 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Sentiment

By Acuity

12 / 438 Finance

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat